Sputnik V - Third vaccine against COVID19 in India

"The first dose of Sputnik V vaccine was administered in Hyderabad”

Sputnik V is the third COVID19 vaccine available in India after Covaxin and Covishield. It is made by Gamaleya Research Institute of Epidemiology and Microbiology, Moscow. It is a two-dose vaccine same as Covishield and Covaxin. This vaccine has an efficacy of 91% as per the researchers. Dr. Reddy’s Laboratories has received 1,50,000 doses of this vaccine from Russia. However, the company expects more doses of it in near future. The first dose of Sputnik V was administered in Hyderabad. 

This vaccine is costing Rs. 995 per dose, this includes 5% of GST. Covishield which is being manufactured by Serum Institute of India, Pune is costing Rs. 300 per dose to States and Rs. 600 per dose to private hospitals. Covaxin is priced at Rs. 400 per dose to States and Rs. 1200 per dose to private hospitals. However, Dr. Reddy’s Laboratories has set the same price for Government and private channels. 

20% initial supply of Sputnik V will be imported from Russia. “There is a commitment of 36 million doses from RDIF (Russian Direct Investment Fund) in next 2 months”, said Vice President, Dr. Reddy’s. The laboratory will soon bring single dose Sputnik Light vaccine in India.

Tags : #Spotlight #SputnikV #DRL #Covishield #PriceofSputnik #FirstdoseofSputnik #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024